Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Drug-coated Balloon Angioplasty in Sri Lanka
Author(s): Yanushka Herath , Judy Ranaweera , Thisal Semina , et al Added: 2 months ago

Intervention

Prevention & Chronic Conditions
TCT 24: The ECLIPSE Trial
Author(s): Ajay J Kirtane Added: 1 year ago
TCT Conference 2024 - Routine use of orbital atherectomy system (OAS) did not improve minimal stent area (MSA) or target vessel failure (TVF) at one year compaared to conventional balloon angioplasty.Dr Ajay J Kirtane (Columbia University Medical Center and New York-Presbyterian Hospital, New York, US) joins us onsite at TCT Conference to discuss the findings from ECLIPSE (NCT03108456; Abbott… View more

Intervention
TCT 23: AGENT IDE
Author(s): Robert Yeh Added: 2 years ago
TCT 23 - In this short online interview, we are joined by Dr Robert Yeh (Beth Israel Deaconess Medical Center, US) to discuss the findings of the AGENT IDE trial (NCT04647253), sponsored by Boston Scientific. AGENT IDE is a prospective, 2:1 randomized multicenter trial that aimed to compare the AGENT paclitaxel-coated balloon to plain-old balloon angioplasty (POBA) with a commercially available… View more

Intervention
TCT 24: Sirolimus- vs. Paclitaxel-Coated Balloon Angioplasty
Author(s): Ulf Teichgräber Added: 1 year ago
TCT Conference 2024 - Safety and efficacy outcomes of the trial shows that percutaneous transluminal angioplasty (PTA) with the sirolimus drug coated balloon (DCB) in patients with femoropopliteal artery disease was/was not noninferior to PTA with the paclitaxel DCB.Prof Ulf Teichgräber joins us onsite at TCT Conference to discuss the findings from the sirolimus- vs. paclitaxel-coated balloon… View more

Intervention

Vascular Disease and Surgery
TCT 2025: Short-CUT: Lithotripsy Vs Cutting Balloon for CAD
Author(s): Suzanne J Baron Added: 3 months ago
TCT 2025 — Dr Suzanne J Baron (Massachusetts General Hospital, US), principal investigator of the Short-CUT trial (NCT06089135; Baim Institute for Clinical Research), joins us to discuss this investigator-initiated, multicentre randomized controlled study.The trial enrolled 410 patients with moderate to severe coronary artery calcification across up to 22 international sites. Eligible… View more

Intervention
LINC 25: The GRIFFIN Study
Author(s): Tatsuya Nakama Added: 1 year ago
LINC 2025 - Outcomes from the GRIFFIN study suggest post-procedural functional flow reserve (FFR) could be a useful predictor of restenosis after drug-coated balloon (DCB) angioplasty for superficial femoral artery (SFA) lesions. Restenosis patients showed significantly lower FFR values than non-restenosis patients, and the study resulted in a good FFR cut-off value of restenosis after DCB… View more

Intervention

Vascular Disease and Surgery
Saib Khogali
Research Area(s) / Expertise:

Structural Intervention

Coronary Interventions

 Job title: Consultant Interventional Cardiologist and Honorary Senior Clinical Lecturer. Coronary interventions and Lead for Structural Heart Intervention, New Cross Hospital, Wolverhampton, UK
Dr. Saib Khogali is a renowned Consultant Cardiologist at the Heart & Lung Centre, New Cross Hospital, Wolverhampton. He also serves as an Honorary Senior Clinical Lecturer at the University of Birmingham. As a key member of a specialist team, Dr. Khogali has been instrumental in launching and establishing a comprehensive coronary angioplasty and stenting program, as well as enhancing emergency… View more
image
Research Area(s) / Expertise: Job title: Interventional Cardiologist
Interventional Cardiologist, Instituto Cardiovascular de Buenos Aires (ICBA) His areas of interest have centered around Coronary, complex angioplasty, chronic total occlusion angioplasty and structural heart disease interventions. View more
View from the Thoraxcenter: What's Hot at EuroPCR 24?
Author(s): Nicolas M Van Mieghem , Joost Daemen Added: 1 year ago
What's hot at EuroPCR 2024?Join interventional experts, Prof Nicolas Van Mieghem and Dr Joost Daemen from Erasmus MC's Thoraxcenter for an insightful preview of the late-breaking science data to look out for at the 2024 EuroPCR meeting.What is the potential impact of the new data on practice? What details should we look out for? What is the context of the EuroPCR trials?Trials covered included:00… View more

Intervention
CRT 25: AGENT IDE: 2Y Outcomes
Author(s): Jeffrey W Moses Added: 11 months ago
CRT 25 - Safety and effectiveness outcomes of the Agent drug-coated balloon (DCB) for the treatment of in-stent restenosis show a major reduction in target lesion failure, including cardiac death, myocardial infarction and target lesion revascularization, compared to balloon angioplasty. The Agent DCB also caused a significant reduction in all target lesion events in comparison with the control… View more

Intervention

Vascular Disease and Surgery